Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells

Rajesh R. Nair, Michael F. Emmons, Anne E. Cress, Raul F. Argilagos, Kit Lam, William T. Kerr, Hong-Gong Wang, William S. Dalton and Lori A. Hazlehurst
Rajesh R. Nair
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael F. Emmons
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne E. Cress
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raul F. Argilagos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kit Lam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William T. Kerr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong-Gong Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William S. Dalton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lori A. Hazlehurst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-09-0113 Published August 2009
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: August 2009 to January 2021

AbstractFull-text HTMLPDF
Total265021671349

Cited By

Article Information

Volume 8, Issue 8, pp. 2441-2451

DOI 
https://doi.org/10.1158/1535-7163.MCT-09-0113
PubMed 
19671765

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received February 10, 2009
  • Revision received May 28, 2009
  • Accepted June 8, 2009
  • Published first August 11, 2009.

Article Versions

  • Previous version (August 11, 2009 - 08:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009 American Association for Cancer Research.

Author Information

  1. Rajesh R. Nair1,
  2. Michael F. Emmons1,
  3. Anne E. Cress5,
  4. Raul F. Argilagos1,
  5. Kit Lam6,
  6. William T. Kerr2,
  7. Hong-Gong Wang3,
  8. William S. Dalton4 and
  9. Lori A. Hazlehurst1,4
  1. 1Molecular Oncology, 2Immunology, 3Drug Discovery, and 4Experimental Therapeutics Programs, Moffitt Cancer Center, Tampa, Florida; 5Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona; and 6Internal Medicine, University of California Davis, Davis, California
  1. Requests for reprints:
    Lori Hazlehurst, Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33613. Phone: 813-903-6807; Fax: 813-979-7265. E-mail: Lori.Hazlehurst{at}moffitt.org
  1. R.R. Nair and M.F. Emmons contributed equally to the manuscript.

View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 8 (8)
August 2009
Volume 8, Issue 8
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells
Rajesh R. Nair, Michael F. Emmons, Anne E. Cress, Raul F. Argilagos, Kit Lam, William T. Kerr, Hong-Gong Wang, William S. Dalton and Lori A. Hazlehurst
Mol Cancer Ther August 1 2009 (8) (8) 2441-2451; DOI: 10.1158/1535-7163.MCT-09-0113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells
Rajesh R. Nair, Michael F. Emmons, Anne E. Cress, Raul F. Argilagos, Kit Lam, William T. Kerr, Hong-Gong Wang, William S. Dalton and Lori A. Hazlehurst
Mol Cancer Ther August 1 2009 (8) (8) 2441-2451; DOI: 10.1158/1535-7163.MCT-09-0113
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • PX-478 Radiosensitization in Pancreatic Cancer
  • Metronomic Gemcitabine Inhibits Pancreatic Cancer
  • p53-Deficient Cells Are More Sensitive to Plk1 Inhibitor
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement